Abstract:Pain is a significant global health issue, and the current treatment options for pain management have limitations in terms of effectiveness, side effects, and potential for addiction. There is a pressing need for improved pain treatments and the development of new drugs. Voltage-gated sodium channels, particularly Nav1.3, Nav1.7, Nav1.8, and Nav1.9, play a crucial role in neuronal excitability and are predominantly expressed in the peripheral nervous system. Targeting these channels may provide a means to treat pain while minimizing central and cardiac adverse effects. In this study, we construct protein-protein interaction (PPI) networks based on pain-related sodium channels and develop a corresponding drug-target interaction (DTI) network to identify potential lead compounds for pain management. To ensure reliable machine learning predictions, we carefully select 111 inhibitor datasets from a pool of over 1,000 targets in the PPI network. We employ three distinct machine learning algorithms combined with advanced natural language processing (NLP)-based embeddings, specifically pre-trained transformer and autoencoder representations. Through a systematic screening process, we evaluate the side effects and repurposing potential of over 150,000 drug candidates targeting Nav1.7 and Nav1.8 sodium channels. Additionally, we assess the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of these candidates to identify leads with near-optimal characteristics. Our strategy provides an innovative platform for the pharmacological development of pain treatments, offering the potential for improved efficacy and reduced side effects.

What problem does this paper attempt to address?

### Problems the Paper Aims to Solve This paper aims to address the limitations of existing pain management treatments, which include limited efficacy, numerous side effects, and potential for addiction. Specifically, the research focuses on the critical role of voltage-gated sodium channels (particularly Nav1.3, Nav1.7, Nav1.8, and Nav1.9) in neuronal excitability, which are primarily expressed in the peripheral nervous system. By targeting these channels, new pain treatment methods can be developed to reduce central and cardiac adverse effects. ### Main Methods 1. **Constructing Protein-Protein Interaction (PPI) Networks**: - Using the String database to construct PPI networks related to pain-associated sodium channels (Nav1.3, Nav1.7, Nav1.8, and Nav1.9). - Screening 111 inhibitor datasets from these networks, containing over 150,000 drug candidates. 2. **Developing Drug-Target Interaction (DTI) Networks**: - Utilizing natural language processing (NLP) tools (such as autoencoders and transformers) to embed representations of inhibitor compounds. - Combining gradient boosting decision tree (GBDT), support vector machine (SVM), and random forest (RF) algorithms to construct binding affinity (BA) prediction models. 3. **Evaluating Side Effects and Repurposing Potential**: - Assessing the side effects and repurposing potential of over 150,000 compounds through cross-prediction. - Evaluating the side effects of FDA-approved drugs or other existing drugs and identifying potential lead compounds. 4. **ADMET Screening**: - Assessing the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of compounds to screen for near-optimal lead compounds. ### Objectives - Provide an innovative platform for analyzing pain management and developing new therapeutic drugs. - Improve the efficiency and accuracy of drug development through machine learning and virtual drug screening technologies, reducing experimental costs and time. ### Keywords - Pain Management - Voltage-Gated Sodium Channels - Protein-Protein Interaction - Drug-Target Interaction - Machine Learning - Virtual Drug Screening - Repurposing - ADMET Through these methods, the research team hopes to develop more effective pain treatment drugs with fewer side effects.

Machine Learning Study of the Extended Drug-target Interaction Network informed by Pain Related Voltage-Gated Sodium Channels

Predicting the Mechanism of Tiannanxing-shengjiang Drug Pair in Treating Pain Using Network Pharmacology and Molecular Docking Technology

Specific Subunits of Voltage-Gated Sodium Channel Underlying the Subthreshold Membrane Potential Oscillations: Potential Therapeutic Targets for Neuropathic Pain

Recent advances in small molecule Nav 1.7 inhibitors for cancer pain management

Prediction and Optimization of NaV1.7 Sodium Channel Inhibitors Based on Machine Learning and Simulated Annealing.

Targeting Long‐term Depression of Excitatory Synaptic Transmission for the Treatment of Neuropathic Pain

Drug discovery targeting Nav1.8: Structural insights and therapeutic potential

Bioinformatics Analysis of the Regulatory Lncrna-Mirna-mrna Network in Patients with Neuropathic Pain and Prediction of Potential Therapeutics

Novel Neural Network Approach to Predict Drug-Target Interactions Based on Drug Side Effects and Genome-Wide Association Studies

A deep learning framework combining molecular image and protein structural representations identifies candidate drugs for pain

Sodium Channel Inhibitors (Nav1.7, 1.8, And 1.9) For Neuropathic Pain Management

Discovery of E0199: A Novel Compound Targeting Both Peripheral NaV and KV7 Channels to Alleviate Neuropathic Pain

Predicting pain genes: multi-modal data integration using probabilistic classifiers and interaction networks

Identification of N-(((1S,3R,5S)-adamantan-1-yl)methyl)-3-((4-chlorophenyl)sulfonyl)benzenesulfonamide as novel Nav1.8 inhibitor with analgesic profile

Network-Based Drug Discovery: Coupling Network Pharmacology with Phenotypic Screening for Neuronal Excitability

Computational Pipeline to probe NaV1.7 gain-of-functions variants in neuropathic painful syndromes

In silico identification of A1 agonists and A2a inhibitors in pain based on molecular docking strategies and dynamics simulations

Selective Activation of TASK-3-containing K+ Channels Reveals Their Therapeutic Potentials in Analgesia

Computational modeling to study the impact of changes in Nav1.8 sodium channel on neuropathic pain

Machine-learning analysis of opioid use disorder informed by MOR, DOR, KOR, NOR and ZOR-based interactome networks

Nav1.7 Modulator Bearing a 3-Hydroxyindole Backbone Holds the Potential to Reverse Neuropathic Pain